Your email has been sent.
Cibus 2800 Mount Ridge Rd 49,069 SF Office Building Roseville, MN 55113 $18,000,000 ($366.83/SF) 8.22% Cap Rate



Investment Highlights
- Absolute NNN Lease - Zero Landlord Responsibilities
- State-of-the-Art Facility in place I/O at 3.61% through 2029
- 5 Minutes to Downtown Minneapolis, 8 Minutes to Downtown St. Paul
- Corporate Guarantee – Cellectis S.A. (NASDAQ: CLLS)
- 2018 Class-A Construction on 11-Acre Corporate Campus Located Within 280-Acre Master-Planned Mixed-Use Redevelopment
- Strong 5-Mile Demographics – 285,584 Residents and 238,011 Daytime Employees
Executive Summary
Completed in 2018, the property is a Class A facility situated on an 11-acre corporate campus. It includes advanced laboratory and research space, a test kitchen, greenhouse, and outdoor demonstration plots, making it a mission-critical location for Cibus, a leader in precision gene editing for agriculture. The property is conveniently located just five minutes from Downtown Minneapolis and eight minutes from Downtown St. Paul, with immediate access to I-35W, which carries more than 139,000 vehicles per day.
The property is part of a 280-acre master-planned redevelopment featuring high-density residential, Class A office and industrial space, retail, and hospitality. It is supported by strong demographics, including more than 285,000 residents within a five-mile radius and a daytime population of over 238,000 employees. Average household income exceeds $99,000 within one mile. Nearby, Rosedale Center attracts more than 14 million visitors annually following a $100 million renovation. The area also offers a wide variety of restaurants, hotels, entertainment options, and outdoor recreation at Langton Park.
Property Facts
Major Tenants Click Here to Access
- Tenant
- Industry
- SF Occupied
- Rent/SF
- Lease Type
- Lease End
-
- Professional, Scientific, and Technical Services
- -
-
$9.99
-
Lorem Ipsum
-
Jan 0000
Cibus has developed plant and microbial platforms enabling it to become a world leader in precision gene editing, generally, and advanced non-transgenic breeding, specifically. The Rapid Trait Development System (RTDS™), its proprietary technology for non-transgenic breeding, enables site-specific edits of native genes with no introduction of foreign DNA. The precise and predictable outcomes can replicate products developed using traditional mutagenesis and are identical to those that could occur in nature, given enough time. Cibus has launched its first commercial crop, SU Canola™, a non-transgenic canola tolerant to sulfonylurea herbicides in the United States, and has received regulatory approval in Canada, putting the trait on track to launch there after 2016. The Cibus family includes the team of founding scientists and executives, and has grown to more than 100 employees who provide extensive backgrounds across a number of disciplines.
| Tenant | Industry | SF Occupied | Rent/SF | Lease Type | Lease End | |
|
Professional, Scientific, and Technical Services | - | $9.99 | Lorem Ipsum | Jan 0000 |
Property Taxes
| Parcel Numbers | Improvements Assessment | $4,289,600 | |
| Land Assessment | $4,531,100 | Total Assessment | $8,820,700 |

